Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 May 7;24(11):e1197–e1211. doi: 10.1634/theoncologist.2018-0876

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. The Oncologist published by Wiley Periodicals, Inc. on behalf of AlphaMed Press.

This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

PMC Copyright notice

Three‐year overall survival by LDH status with BRAF‐MEK combination therapy and checkpoint immunotherapy in metastatic melanoma.

Abbreviations: D, dabrafenib; I, ipilimumab; LDH, lactate dehydrogenase; N, nivolumab; OS, overall survival; P, pembrolizumab; T, trametinib; ULN, upper limit of normal.